Chief Executive Officer
Glen is a Partner at VedaPointe, and a Senior Healthcare Technology Executive with nearly 25 years of experience in Information Technology. He focuses on the strategic use of technology and data to build successful businesses. Glen tackles high-threat business situations, turning around failed strategy and performance, and applying technology solutions to produce significant revenue and market growth. He is highly-regarded as an innovative leader, with the vision to create forward-looking technologies in a rapidly changing environment.
Glen spent over a decade as the Chief Technology Officer of Centene Corporation, managing the organization’s growth from $1B in revenue to its status as a Fortune 100 company with over $40B in annual revenue and more than 30,000 employees. At Centene, Glen led the change in Information Technology from a back-office asset to front-line differentiator. He implemented care management solutions, best-in-class analytic capabilities, and competitive clinical technologies that helped Centene become the Nation’s leader in low-income and government-sponsored healthcare.
Prior to Centene, Glen was a Partner with Accenture where he led the delivery of complex solutions and large-scale IT transformation projects in Fortune 100 organizations including United Health Group, Walgreens, and Deluxe Corporation. At Accenture, Glen was known for leading high-performing teams, as well as, developing and implementing technologies that improved client performance in business development, marketing, operations, and customer service.
Complementing Glen’s professional experience is an education that includes an Executive MBA from Washington University in St. Louis, Missouri, and a Bachelor of Science Degree in Electrical Engineering from the University of Illinois at Urbana-Champaign.
Today, Glen is President, Chief Executive Officer and Partner at VedaPointe, LLC where he leads a powerful team of analysts and technologists focused on both the strategic use of data in healthcare, and the creation of products that accelerate effective technology use cases for clinical, operational, and financial value.